Osteo Arthritis Knee: Clinical Trials

10 trials for Osteo Arthritis Knee, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 not yet recruiting, 1 active not recruiting, 1 enrolling by invitation. 10 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 3, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 22Completed 1, Not yet recruiting 1

Follow Osteo Arthritis Knee: new trials by email Literature Review of Osteo Arthritis Knee trials Research Report on Osteo Arthritis Knee

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
Gene Therapy GNSC-001, Placebo - Knee Arthritis Osteoarthritis, Knee Arthritis, Osteoarthritis
Phase 2 / Phase 3Not yet recruitingGenascence Corporation2402027-07-012026-09-21
Extended Oral Tranexamic Acid After Total Knee Arthroplasty
Tranexamic acid, Placebo - Osteo Arthritis Knee, Pain, Postoperative
Phase 3Enrolling by invitationCampbell Clinic1202024-09-172026-08-13
Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis
Microfragmented Adipose Tissue derived using the Lipogems® System, Saline Injection - Knee Osteoarthritis, Osteo Arthritis Knee
Phase 3Active not recruitingLipogems International spa1732024-03-152025-06-12
Comparison Between Intra-articular Infiltrations of PRP, MFAT, and PRP-MFAT in the Treatment of Symptomatic Knee Osteoarthritis.
Intra-articular injection of autologous microfat, Intra-articular injection of autologous platelet-rich plasma, Intra-articular injection of autologous microfat and platelet-rich plasma - Osteo Arthritis Knee
Phase 3Not yet recruitingAssistance Publique Hopitaux De Marseille1802024-02-022023-10-27
Metformin Safety and Efficacy in Osteoarthritis.
Celecoxib 200mg, Metformin - Osteo Arthritis Knee
Phase 3RecruitingMostafa Bahaa702024-01-302026-03-13
A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
Retatrutide, Placebo - Obesity, Overweight
Phase 3CompletedEli Lilly and Company4452023-08-012026-01-21
Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis
Microfragmented Adipose Tissue, Corticosteroid - Knee Osteoarthritis, Osteo Arthritis Knee
Phase 3CompletedLipogems International spa1732022-12-302025-04-22
Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is Delayed
Resiniferatoxin, Placebo - Osteoarthritis, Knee, Osteo Arthritis Knee
Phase 3WithdrawnSorrento Therapeutics, Inc.2021-04-012021-11-09
Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee
Leukocyte-rich platelet-rich plasma, Leukocyte-poor platelet-rich plasma, Corticosteroid - Osteo Arthritis Knee
Phase 2 / Phase 3CompletedQueen Savang Vadhana Memorial Hospital, Thailand932020-08-032023-02-21
Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
bone marrow mesenchymal stem cells, Adipose Mesenchymal stem cells, bone marrow & adipose mesenchymal stem cells injection - Osteo Arthritis Knee
Phase 3UnknownUniversidad Catolica Santiago de Guayaquil542020-06-072020-04-17

Narrower conditions

Osteoarthritis, Knee (4)  ·  Osteoarthritis (2)  ·  Obesity (1)  ·  Overweight (1)  ·  Pain (1)  ·  Pain, Postoperative (1)

Broader conditions

Arthritis (5)  ·  Joint Diseases (5)  ·  Musculoskeletal Diseases (5)  ·  Rheumatic Diseases (5)  ·  Osteoarthritis (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Neurologic Manifestations (2)  ·  Body Weight (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Postoperative Complications (1)

Interventions

Adrenal Cortex Hormones (2)  ·  Celecoxib (1)  ·  Metformin (1)  ·  Sodium Chloride (1)  ·  Steroids (1)  ·  Tranexamic Acid (1)  ·  microcrystalline cellulose (1)  ·  resiniferatoxin (1)  ·  retatrutide (1)

Sponsors

Lipogems International spa (2)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Campbell Clinic (1)  ·  Eli Lilly and Company (1)  ·  Genascence Corporation (1)  ·  Mostafa Bahaa (1)  ·  Queen Savang Vadhana Memorial Hospital, Thailand (1)  ·  Sorrento Therapeutics, Inc. (1)  ·  Universidad Catolica Santiago de Guayaquil (1)

Countries

United States (4)  ·  Australia (1)  ·  Canada (1)  ·  Ecuador (1)  ·  Egypt (1)  ·  Mexico (1)  ·  Spain (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Carlos A Chiriboga, MD (1)  ·  Christopher Holland, MD, MS (1)  ·  Monica Luchi, MD (1)  ·  Surapol Athiprayul, MD (1)

Results publications

PMID 11869080, PMID 12081113, PMID 16263424, PMID 1991946, PMID 20603892, PMID 23831631, PMID 24449146, PMID 25035839, PMID 25161985, PMID 25925602, PMID 25944079, PMID 26432430, PMID 27229856, PMID 28012636, PMID 28386761, PMID 30623236, PMID 30632533, PMID 34826301, PMID 35103547

NIH funding

2023 (1)